Research Roundup


Debbie Rigby rounds up the latest in research news Irritable bowel syndrome: low-dose antidepressant improves symptoms Low dose of amitriptyline (10mg daily for 6 months) improves overall symptoms and abdominal pain of irritable bowel syndrome compared to placebo. In the ATLANTIS trial, low-dose amitriptyline was safe, and well tolerated. BMJ 2024;385:q871. Generating and translating evidence

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous 2024 Dr Erica Sainsbury Awards winners announced
Next CAPS seeks to ‘rock the vote’